MedTrace Logo

The Effect of Continuous, Various Doses of Furosemide Drip on Hearing as Measured by Acoustic Emission

NCT00945386 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2009-07-24

No results posted yet for this study

Summary

Pediatric patients, during their illness often treated with furosemide (Lasix) continuous drip, often, with dosages above 4-6mg/kg/day (the recommended dose).

This study will monitor hearing status of these children prior to their therapy with furosemide, during this therapy and after.

Conditions

  • Hearing Status

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Elhanan Nahum, MD · Schneider Children's Hospital

Eligibility

Min Age
1 Month
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Completion
2010-08-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00945386 on ClinicalTrials.gov